Overview
Status
Active
Registry date
2015-04-15
Share capital
40,000.00 PLN
Registered address
ul. Józefa Bema 1/2, 20-045 Lublin, Poland
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $2,628 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 87 days late).
- 2025filed
- 202427/06/2025
- 202313/05/2024
- 202228/06/2023
- 202110/10/2022
- 202006/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations98 / 230
Top 43%
Results vs industry
Revenue
This companyUSD 1.82mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 40.45kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 1.72mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 700.97kMedianUSD 897.46kAverageUSD 31.52m
Industry
Authorized Representatives
Olga Dąbrowska age 44 – President of the Management Board
Manner of representation
In the case of a multi-member management board, each member of the management board submits declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Olga Dąbrowska age 44 | 25 | $2,701.24 | 25% |
Andrzej Dąbrowski age 52 | 75 | $8,103.73 | 75% |
Andrzej Dąbrowski and Olga Dąbrowska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-04-24.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo Farmaceutyczne S.A. | $111,469,394.21 | anpharm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A. | $119,621,017.71 | hasco-lek.pl | ||
| Polfarmex S.A. | $73,543,379.32 | polfarmex.pl | ||
| Celon Pharma S.A. | $52,550,739.16 | celonpharma.com | ||
| Medicofarma S.A. | $8,530,473.72 | medicofarma.pl | ||
| Vitama S.A. | $4,287,087.38 | vitama.pl | ||
| Biomar sp. z o.o. | $909,113.28 | biomar.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polański sp. z o.o. | $893,738.50 | lekinatury.pl | ||
| Human Biome S.A. | $888,361.19 | human-biome.com | ||
| Powerpharma sp. z o.o. | – | powerpharma.eu |
Change history
| Date | Event | |
|---|---|---|
| 2024-02-21 | Business resumed | |
| 2023-01-05 | Business suspended | |
| 2018-02-09 | Name change (Olan Pharm → Olan Invest) | |
| 2017-12-20 | Address change (Ul. Marii Curie-Skłodowskiej 32/2, 20-029, Lublin → Ul. Józefa Bema 1/2, 20-045, Lublin) | |
| 2015-04-15 | Entered in the register |
FAQ
The main business activity of Olan Invest focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on April 15, 2015.
The headquarters is located at: ul. Józefa Bema 1, 20-045 Lublin.
The management board consists of: Olga Dąbrowska (President of the Management Board).
The share capital of the company is PLN 40,000 (approx. $10,805).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
Last updated: 2026-04-11
